about
Role of cytochrome P450 in drug interactionsMedication and the elderly. Issues of prescription and use.Epidemiology, outcomes research, and drug interactions.Gender differences in depression and antidepressant pharmacokinetics and adverse events.The influence of age and smoking on the elimination of disopyramide.The effect of cigarette smoking on 7-ethoxyresorufin O-deethylase and other monooxygenase activities in human liver: analyses with monoclonal antibodiesAntipyrine clearance and metabolism in patients with psoriasis.Effects of tobacco smoking and oral contraceptive use on theophylline disposition.Induction of drug-metabolizing enzymes by tricyclic antidepressants in human liver: characterization and partial resolution of cytochromes P-450.Does smoking interfere with the effect of histamine H2-receptor antagonists on intragastric acidity in man?A review and assessment of potential sources of ethnic differences in drug responsiveness.Use of low-dose oral theophylline as an adjunct to inhaled corticosteroids in preventing exacerbations of chronic obstructive pulmonary disease: study protocol for a randomised controlled trial.Metabolism of nicotine.Influence of cigarette smoking on drug metabolism in man.The application of clearance concepts to propranolol disposition in man.Drug metabolism in the elderly: confounding of age, smoking, and ethanol effects.Ethnicity and antipsychotic response.Cigarette smoking and clinically significant drug interactions.Enzyme induction and beta-adrenergic receptor blocking drugs.Differential effects of enzyme induction on antipyrine metabolite formation.Cigarette smoking enhances the elimination of quinine.Modification of propranolol's bioavailability by Eurycoma longifolia water-based extract.Lack of influence of cigarette smoking on triazolam pharmacokinetics.Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.Theophylline kinetics in relation to age: the importance of smoking.Coffee consumption, cigarette smoking and reporting of drowsiness in anxious patients treated with benzodiazepines or placebo.
P2860
Q21245066-9A3038A6-0B08-4A8B-95C5-BF8B18272D73Q33630080-A1C1D814-50F5-4122-BB51-12D99C564B52Q33656679-A003D1D5-CEC4-453D-A7A7-ECF56EB0AC46Q33834884-6E723A0A-94F9-42D3-9D24-0DA02F206EADQ34446722-679911C7-1871-49C7-8CD1-C8B0F5B580E6Q34447852-4457FBA7-F74E-4721-9021-294D62EF0DB5Q34448073-24FF456F-A688-4B61-9297-BB6A822D65E5Q34513078-27512070-3257-46C2-88FF-CF36971334A2Q34514212-79BC0E19-E438-4ED5-9D12-A8E2DA4DB42CQ34527457-0732E367-3545-4A94-921A-09172C67E130Q35217493-84C72C1D-2A4F-40F6-9E9F-20722A481AB7Q35733010-CE3E2492-BE5B-4E5C-BBAC-5E19E70E897DQ37238140-D6708F99-FB71-41C0-9553-2CFF7E46F65CQ39808606-C49E1BDF-25BA-4C51-8419-13452B1B64D1Q39850162-520CFB2D-6DBC-44AE-B7F7-F0BE04EFF612Q40147811-1F093BB7-DEAB-4880-8899-EB5CD972E1DDQ40876700-23FDF51C-AEC1-4872-AFC7-BDF38F1C0519Q40952943-E2A9DCE3-8832-4BF7-B4EF-C64ADF007BCFQ41987008-C32464D5-7AE9-45BE-8CFC-3D0C900A8FC6Q42021525-E45A9479-67A9-4311-8D71-0BA110FE43C1Q42028459-BEE8A6CD-71B0-40E1-9A41-9906CD4E55ABQ42835363-983F953E-087A-4D59-A5AA-4D7203AEA126Q43228889-E2D5660D-BB56-4D9C-B616-428CEDE84D52Q43228961-1F12C70F-C624-48A1-807A-47E31637C2F9Q43243670-8216F28C-8638-480B-9973-C05EA18FFBEDQ49160897-CCDF9D6F-A873-40F2-A874-19ACFEE09F46
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Role of tobacco smoking in pharmacokinetics.
@en
Role of tobacco smoking in pharmacokinetics.
@nl
type
label
Role of tobacco smoking in pharmacokinetics.
@en
Role of tobacco smoking in pharmacokinetics.
@nl
prefLabel
Role of tobacco smoking in pharmacokinetics.
@en
Role of tobacco smoking in pharmacokinetics.
@nl
P2860
P356
P1476
Role of tobacco smoking in pharmacokinetics.
@en
P2093
P2860
P2888
P356
10.1007/BF01066061
P577
1978-02-01T00:00:00Z